Kidney Biomarkers May Help Identify Older Adults’ Risk for Cognitive and Physical Decline
Patients with chronic kidney disease, end-stage renal disease, and kidney failure commonly experience accelerated aging. In addition, poor cognition has...
Decline
Chronic kidney disease accelerates cognitive decline through heart-brain pathways
A new study published in the American Journal of Physiology - Heart and Circulatory Physiology reveals that chronic kidney disease (CKD) accelerates cognitive decline through interconnected damage...
Mitochondrial DNA Damage Tied to Kidney Decline
Kidney damage that seemingly heals appears to mutate the DNA in the mitochondria of kidney cells, making the organ less...
Gross Hematuria After COVID Vaccination Linked to Short-Term Kidney Function Decline in IgAN
New research is shedding light on increases in short-term kidney function decline following post-COVID-19 vaccination gross hematuria (GH) in individuals...
Ozempic approved in Canada to slow kidney decline, prevent cardiovascular disease
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.Between 30...
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease | Trials
Explanation for the choice of comparators {6b}Participants in the control group will receive matched identical placebo. A placebo-controlled trial was...
